The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001639:Bicarbonates / Q000008:administration & dosage*; D001672:Biocompatible Materials / Q000737:chemistry* / Q000592:standards; D002470:Cell Survival / Q000187:drug effects; D015314:Dialysis Solutions / Q000737:chemistry* / Q000592:standards; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism; D019344:Lactic Acid / Q000008:administration & dosage*; D008422:Materials Testing; D051379:Mice; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D009930:Organic Chemicals; D010537:Peritoneum / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D016897:Respiratory Burst / Q000187:drug effects
D001639:Bicarbonates; D001672:Biocompatible Materials; D015314:Dialysis Solutions; D017127:Glycation End Products, Advanced; D016209:Interleukin-8; D009930:Organic Chemicals; C488052:Physioneal 35; C488051:Physioneal 40; D019344:Lactic Acid; D000255:Adenosine Triphosphate